These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24160556)

  • 1. Comment on: Clinical benefits of ezetimibe: absence of proof is just that.
    Doggrell SA
    Expert Opin Pharmacother; 2013 Dec; 14(18):2611-2. PubMed ID: 24160556
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
    Gouni-Berthold I; Mikhailidis DP; Rizzo M
    Expert Opin Pharmacother; 2012 Oct; 13(14):1985-8. PubMed ID: 22946714
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the Editor: The ezetimibe 'controversy' is a misunderstanding.
    Spence JD
    Expert Opin Pharmacother; 2012 Dec; 13(17):2579-80; author reply 2580. PubMed ID: 22998481
    [No Abstract]   [Full Text] [Related]  

  • 4. Reaching target LDL cholesterol has become more affordable with launch of ezetimibe/simvastatin combination in South Africa.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(5):291. PubMed ID: 20972520
    [No Abstract]   [Full Text] [Related]  

  • 5. Ezetimibe/simvastatin: a guide to its clinical use in hypercholesterolemia.
    Lyseng-Williamson KA
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):49-56. PubMed ID: 22208355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study.
    Galin ID; Smith DA
    Am Heart J; 2006 May; 151(5):e1. PubMed ID: 16644302
    [No Abstract]   [Full Text] [Related]  

  • 7. Zetia and Zocor: good together? New combo pill Vytorin may help some reach low LDL goals.
    Harv Health Lett; 2005 Feb; 30(4):3. PubMed ID: 15776505
    [No Abstract]   [Full Text] [Related]  

  • 8. The ezetimibe controversy - can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together?
    Doggrell SA
    Expert Opin Pharmacother; 2012 Jul; 13(10):1469-80. PubMed ID: 22725704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Author's response.
    Gouni-Berthold I; Mikhailidis DP; Rizzo M
    Expert Opin Pharmacother; 2013 Dec; 14(18):2612-3. PubMed ID: 24371844
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia.
    Florentin M; Liberopoulos EN; Moutzouri E; Rizos CV; Tselepis AD; Elisaf MS
    Curr Med Res Opin; 2011 Mar; 27(3):685-92. PubMed ID: 21271793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of ezetimibe.
    Ashikaga H; Blumenthal RS; Jones SR
    Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279
    [No Abstract]   [Full Text] [Related]  

  • 12. The IMPROVE-IT study and ezetimibe.
    Signy J; Signy M
    Br J Community Nurs; 2015 May; 20(5):243-4. PubMed ID: 25993373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lowering cholesterol becomes easier. Combining instead of increasing dosage].
    MMW Fortschr Med; 2003 Jan; 145(3-4):59. PubMed ID: 12619241
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.
    Tomassini JE; Mazzone T; Goldberg RB; Guyton JR; Weinstock RS; Polis A; Jensen E; Tershakovec AM
    Diabetes Obes Metab; 2009 Sep; 11(9):855-64. PubMed ID: 19508464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin + ezetimibe: a combination with no proven advantages.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.
    Ballantyne CM; Blazing MA; King TR; Brady WE; Palmisano J
    Am J Cardiol; 2004 Jun; 93(12):1487-94. PubMed ID: 15194018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced hypercholesterolemia therapy: the ezetimibe/simvastatin tablet.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2005 May; 41(5):317-27. PubMed ID: 16082429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
    Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
    Ballantyne CM; Abate N; Yuan Z; King TR; Palmisano J
    Am Heart J; 2005 Mar; 149(3):464-73. PubMed ID: 15864235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ezetimibe, administered alone or in combination with simvastatin, on lymphocyte cytokine release in patients with elevated cholesterol levels.
    Krysiak R; Zmuda W; Okopien B
    J Intern Med; 2012 Jan; 271(1):32-42. PubMed ID: 21623963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.